Portolan Capital Management, LLC United Therapeutics Corp Transaction History

Portolan Capital Management, LLC

$1.29 Billion
Q1 2024

A detailed history of Portolan Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Portolan Capital Management, LLC holds 110,922 shares of UTHR stock, worth $35.3 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares

110,922

Previous 91,808 20.82%

Holding current value

$35.3 Million

Previous $20.2 Million 26.22%

% of portfolio

1.98%

Previous 1.8%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $4.03 Million - $4.77 Million	19,114 Added 20.82%	110,922 $25.5 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $2.31 Million - $2.76 Million	10,760 Added 13.28%	91,808 $20.2 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $10.1 Million - $11.8 Million	47,582 Added 142.18%	81,048 $18.3 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $9.09 Million - $10.3 Million	-44,282 Reduced 56.96%	33,466 $7.39 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $227,686 - $295,225	-1,069 Reduced 1.36%	77,748 $17.4 Million

Q4 2022 Feb 13, 2023	SELL	$205.95 - $280.43 $509,314 - $693,503	-2,473 Reduced 3.04%	78,817 $21.9 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $722,528 - $867,780	-3,554 Reduced 4.19%	81,290 $17 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $14.8 Million - $20.5 Million	84,844 New	84,844 $20 Million
Q3 2020 Nov 16, 2020	SELL	$99.9 - $121.13 $7.5 Million - $9.09 Million	-75,039 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $3.69 Million - $5 Million	-39,738 Reduced 34.62%	75,039 $9.08 Million
Q1 2020 May 14, 2020	BUY	$79.39 - $115.35 $9.11 Million - $13.2 Million	114,777 New	114,777 $10.9 Million
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $3.67 Million - $5.2 Million	-34,227 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $1.42 Million - $1.81 Million	-11,962 Reduced 25.9%	34,227 $5.06 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $5.29 Million - $6.32 Million	46,189	46,189 $5.41 Million

Others Institutions Holding UTHR

# of Institutions

561

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Account

Portolan Capital Management, LLC United Therapeutics Corp Transaction History